Dianne Chan has extensive experience in financial planning, analysis, and operations. Dianne is currently the Director Global Revenue Accounting and Operations at Isologic Innovative Radiopharmaceuticals (ISOLOGIC) since April 2023. Prior to this role, they served as the Senior Manager Financial Planning Analysis at ISOLOGIC from March 2017 to May 2023.
Before joining ISOLOGIC, Dianne worked at Bell Canada as the Senior Manager – Financial Planning & Analysis (FP&A) from December 2008 to March 2017. Dianne also had previous experience at Tata Communications Limited as Senior Manager - Capital Expenditure and MIS Consolidation in 2007, and at VSNL International as Senior Manager - Commission and Special Projects from 2006 to 2007.
Dianne's career started at Teleglobe Inc in 1989, where they held various roles including Senior Manager - Revenue and Sales Support, Associated Director - Sales Administration, Associate Director - Regional Finance, and Senior Financial Advisor - Business Services. Throughout their tenure at Teleglobe Inc, they played a key role in reorganizing the commission department, streamlining the management reporting process, and establishing the post-chapter 11 business plan in 2002.
Dianne Chan completed their Bachelor's degree in Accounting and Finance at Concordia University from 1986 to 1989.
This person is not in any offices
Isologic Innovative Radiopharmaceuticals (ISOLOGIC)
1 followers
Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian radiopharmaceutical company (nuclear pharmacy), dedicated to nuclear medicine and the science of Radiopharmaceutical production. Our commitment to these fields extends to the communities we serve. We utilize our significant experience, expertise and networks in Nuclear Pharmacy to provide our customers and patients with reliable; safe and high quality radiopharmaceutical products and services. ISOLOGIC’s network of SPECT & PET Radiopharmacies, positions us to service Group Purchase Organizations; regional health care systems, as well as stand-alone Independant Healthcare Facilities; clinics and hospitals. Our open formulary of Radiopharmaceutical drugs and medical devices, provides the flexibility of choice, providing our customers access to all radiopharmaceuticals, having Health Canada market authorization. En français : Isologic Innovative Radiopharmaceuticals (ISOLOGIC) est une entreprise radiopharmaceutique canadienne (pharmacie nucléaire), dédiée à la médecine nucléaire et à la science de la production radiopharmaceutique. Notre engagement dans ces domaines s'étend aux communautés que nous servons. Nous utilisons notre expérience, notre expertise et nos réseaux en pharmacie nucléaire pour fournir à nos clients et patients des produits et services radiopharmaceutiques fiables, sûrs et de haute qualité. Le réseau de radiopharmacies SPECT et PET d'ISOLOGIC nous permet de servir les organisations d'achats groupés, les systèmes de santé régionaux, ainsi que les établissements de santé indépendants, les cliniques et les hôpitaux. Notre formulaire ouvert de médicaments radiopharmaceutiques et de dispositifs médicaux offre la flexibilité du choix, en fournissant à nos clients l'accès à tous les produits radiopharmaceutiques, ayant une autorisation de mise sur le marché de Santé Canada.